All News

Found 1,089 articles

• MorphoSys AG and Astellas Pharma Inc. Enter Antibody Partnership -- Deal Seals MorphoSys AG's Third Japanese Pharmaceutical Alliance

  3/28/2007

• MorphoSys AG Announces Change in Supervisory Board -- Supervisory Board Nominates Walter Blattler as Successor of Andreas Pluckthun

  3/26/2007

• MorphoSys AG's AbD Serotec Expands Antibody License Agreement With Medical Research Council

  3/20/2007

• MorphoSys AG Reports Financial Results for Fiscal Year 2006

  2/28/2007

• MorphoSys AG Expands Japanese Alliance With GeneFrontier Corporation

  1/25/2007

• MorphoSys AG Enlarges Therapeutic Antibody Collaboration With Pfizer Inc. - Expansion Doubles Potential Deal Volume For MorphoSys AG

  12/20/2006

• GPC Biotech AG Presents Preliminary Clinical Data On Anticancer Monoclonal Antibody 1D09C3 At American Society of Hematology

  12/11/2006

• MorphoSys AG Presents New RapMAT(TM) Antibody Technology

  12/11/2006

• MorphoSys AG And The Burnham Institute Sign Broad Research Partnership

  11/28/2006

• MorphoSys AG And Boehringer Ingelheim Corporation Expand Collaboration With New Cancer-Related Antibody Program

  11/13/2006

• MorphoSys AG And U.S. Army Enter Into Biodefense Cooperation - MorphoSys AG's AbD Serotec Awarded Sole Supplier Contract To USAMRIID

  9/25/2006

• Crucell N.V. And DSM Biologics Announce Second PER.C6 Licensing Agreement With MorphoSys AG

  8/17/2006

• AbD Serotec Opens New U.S. Office In Research Triangle Region

  8/4/2006

• MorphoSys AG Announces Expansion Of Collaboration With Novartis Corporation

  6/26/2006

• Cambridge Antibody Technology Group PLC Announces Interim Results For The Six Months Ended 31 March 2006

  5/22/2006

• MorphoSys AG And Schering-Plough Corporation Sign R&D Agreement

  5/17/2006

• Thomas von Rüden New CEO Of Direvo Biotech AG

  4/20/2006

• MorphoSys AG And Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance To Develop Novel Antibody Therapies

  3/16/2006

• MorphoSys AG And Roche Expand Therapeutic Antibody Partnership; MorphoSys To Receive Up To $10 Million EURO

  3/1/2006

• MorphoSys AG Achieves Fourth Therapeutic Milestone In Centocor, Inc. Collaboration

  3/1/2006